A strategy for designing allosteric modulators of transcription factor dimerization

Area of Science:

• Molecular Biology
• Cancer Research
• Drug Discovery

Background:

• Transcription factors (TFs) regulate gene expression and can act as oncogenes.
• TF dimerization is crucial for DNA binding and presents a target for drug design.
• Previous studies identified compounds inhibiting OLIG2 dimerization and showing antitumor effects.

Purpose of the Study:

• To validate the mechanism of action for OLIG2 dimerization inhibitors.
• To investigate the effect of compounds on OLIG2 dimerization in live cells.
• To correlate compound potency with observed antitumor activity.

Main Methods:

• Utilized fluorescence cross-correlation spectroscopy (FCCS) in live HEK cells.
• Transfected cells with spectrally distinct OLIG2 clones.
• Analyzed changes in protein diffusion time upon compound treatment.

Main Results:

• Compounds demonstrated potent inhibition of OLIG2 dimerization.
• Inhibition correlated with previously observed antitumor activity.
• Observed changes in OLIG2 diffusion suggest dissociation from DNA.

Conclusions:

• The study validates a drug discovery strategy targeting protein-protein interactions.
• Allosteric modulators of TF dimerization show promise as antitumor agents.
• This approach can be generalized for developing novel cancer therapeutics.